Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ELVN
#1719
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+2.63%
Monatliche Änderung
+13.58%
6 month change
+43.71%
Jahresänderung
+43.71%
Vorheriger Schlusskurs
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
Volumen
140
Märkte
Aktien
Gesundheitswesen
ELVN
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
48.86 M
49 M
49.07 M
59.24 M
59.35 M
—
Valuation ratios
Enterprise value
1.15 B
978.48 M
863.98 M
1.07 B
1.11 B
4.02 B
Price to earnings ratio
-14.85
-11.9
-10.25
-10.03
-11.13
-43.31
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
16.12
14.47
12.9
14.05
14.74
56.17
Price to book ratio
0.95
3.42
0.8
0.72
0.7
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.07
0.09
0.05
0.04
0.26
Return on equity %
0.08
0.07
0.1
0.05
0.04
0.27
Return on invested capital %
464.56
586.3
737.43
637.98
575.25
2 536.97
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
17.44
19.99
21.06
32.58
32.95
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.25
0.37
0.48
0.33
0.21
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
6.05
6.66
5.79
9.41
7.69
29.55
Net current asset value per share
6.15
6.76
5.88
9.51
7.77
29.92
Tangible book value per share
5.98
6.58
5.76
9.37
7.67
29.38
Working capital per share
5.8
6.42
5.6
9.22
7.54
28.78
Book value per share
5.98
6.58
5.76
9.37
7.67
29.38
Nachrichten
Heyman, Enliven Therapeutics director, sells $32k in stock
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Enliven Therapeutics: CSO Lyssikatos verkauft Aktien im Wert von 535.000 US-Dollar
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Enliven Therapeutics: Direktor Heyman veräußert Aktien im Wert von 32.901 US-Dollar
Enliven Therapeutics director Heyman sells $32,901 in stock
Enliven Therapeutics: COO Anish Patel verkauft Aktien im Wert von 1,35 Mio. US-Dollar
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Nach Kursrallye: CSO von Enliven Therapeutics verkauft Aktien im Wert von 3,47 Mio. $
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares
Aktie von Enliven Therapeutics erreicht 52-Wochen-Hoch bei 25,64 USD/n